BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 36801151)

  • 21. Impact of affordable care act on the treatment and outcomes for stage-IV colorectal cancer.
    Jayakrishnan TT; Bakalov V; Chahine Z; Finley G; Monga D; Wegner RE
    Cancer Treat Res Commun; 2020; 24():100204. PubMed ID: 32805532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional variation in the treatment of pancreatic adenocarcinoma: Decreasing disparities with multimodality therapy.
    Kasumova GG; Eskander MF; de Geus SWL; Neto MM; Tabatabaie O; Ng SC; Miksad RA; Mahadevan A; Rodrigue JR; Tseng JF
    Surgery; 2017 Aug; 162(2):275-284. PubMed ID: 28487044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Treatment Inequity and Ancestry With Pancreatic Ductal Adenocarcinoma Survival.
    Heller DR; Nicolson NG; Ahuja N; Khan S; Kunstman JW
    JAMA Surg; 2020 Feb; 155(2):e195047. PubMed ID: 31800002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Impact of Medicaid Expansion on Early-Stage Pancreatic Adenocarcinoma at High- Versus Low-Volume Facilities.
    Lima HA; Moazzam Z; Endo Y; Alaimo L; Woldesenbet S; Munir MM; Shaikh C; Resende V; Pawlik TM
    Ann Surg Oncol; 2023 Nov; 30(12):7263-7274. PubMed ID: 37368099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the 8th AJCC staging system for pathologically versus clinically staged pancreatic adenocarcinoma: A time to revisit a dogma?
    Abdel-Rahman O
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):64-69. PubMed ID: 29428107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer outcomes in low-income elders: is there an advantage to being on Medicaid?
    Koroukian SM; Bakaki PM; Owusu C; Earle CC; Cooper GS
    Medicare Medicaid Res Rev; 2012; 2(2):. PubMed ID: 24800139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are patients of low socioeconomic status receiving suboptimal management for pancreatic adenocarcinoma?
    Cheung MC; Yang R; Byrne MM; Solorzano CC; Nakeeb A; Koniaris LG
    Cancer; 2010 Feb; 116(3):723-33. PubMed ID: 19998350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreatic adenocarcinoma in young adults in a moroccan population.
    Raissouni S; Rais G; Mrabti H; Raissouni F; Mouzount H; Aitelhaj M; El Khoyaali S; Mohtaram A; Errihani H
    J Gastrointest Cancer; 2012 Dec; 43(4):607-11. PubMed ID: 22760710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer Database.
    Shubert CR; Bergquist JR; Groeschl RT; Habermann EB; Wilson PM; Truty MJ; Smoot RL; Kendrick ML; Nagorney DM; Farnell MB
    Surgery; 2016 Oct; 160(4):1080-1096. PubMed ID: 27522556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in Baseline Characteristics and White Blood Cell Ratios Between Racial Groups in Patients with Pancreatic Adenocarcinoma.
    Ueberroth BE; Khan A; Zhang KJ; Philip PA
    J Gastrointest Cancer; 2021 Mar; 52(1):160-168. PubMed ID: 32077005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of socioeconomic status and race on trial participation for older women with breast cancer.
    Gross CP; Filardo G; Mayne ST; Krumholz HM
    Cancer; 2005 Feb; 103(3):483-91. PubMed ID: 15597407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Socioeconomic Disparities Affect Outcomes in Early-Stage Esophageal Adenocarcinoma: A SEER Analysis.
    Geng CX; Gudur AR; Radlinski M; Buerlein RCD; Strand DS; Sauer BG; Shami VM; Wang AY; Podboy A
    Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2797-2806.e6. PubMed ID: 36858145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and resection of pancreatic adenocarcinoma: a large international population-based cohort study.
    Huang L; Balavarca Y; van der Geest L; Lemmens V; Van Eycken L; De Schutter H; Johannesen TB; Zadnik V; Primic-Žakelj M; Mägi M; Grützmann R; Besselink MG; Schrotz-King P; Brenner H; Jansen L
    BMC Med; 2019 Mar; 17(1):66. PubMed ID: 30905320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. It's more than just cancer biology: Health disparities in patients with pancreatic neuroendocrine tumors.
    Underwood PW; Riner AN; Neal D; Cameron ME; Yakovenko A; Reddy S; Rose JB; Hughes SJ; Trevino JG
    J Surg Oncol; 2021 Dec; 124(8):1390-1401. PubMed ID: 34499741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer disparities in the context of Medicaid insurance: a comparison of survival for acute myeloid leukemia and Hodgkin's lymphoma by Medicaid enrollment.
    Yung RL; Chen K; Abel GA; Gesten FC; Roohan PJ; Boscoe FP; Sinclair AH; Schymura MJ; Schrag D
    Oncologist; 2011; 16(8):1082-91. PubMed ID: 21873583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A nationwide analysis of pancreatic cancer trial enrollment reveals disparities and participation problems.
    Hue JJ; Katayama ES; Markt SC; Elshami M; Saltzman J; Bajor D; Hosmer A; Mok S; Dumot J; Ammori JB; Rothermel LD; Hardacre JM; Winter JM; Ocuin LM
    Surgery; 2022 Jul; 172(1):257-264. PubMed ID: 34839935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethnic and racial disparities of pancreatic adenocarcinoma in Florida.
    Fagenson AM; Grossi SM; Musgrove K; Solomon N; de la Vega PR; Castro G; Pitt HA; Varella M; Zavallos J; Acuna J
    HPB (Oxford); 2020 May; 22(5):735-743. PubMed ID: 31601507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment and survival vary by race/ethnicity in patients with anaplastic thyroid cancer.
    Roche AM; Fedewa SA; Shi LL; Chen AY
    Cancer; 2018 Apr; 124(8):1780-1790. PubMed ID: 29409119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
    Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
    World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study.
    Saad AM; Turk T; Al-Husseini MJ; Abdel-Rahman O
    BMC Cancer; 2018 Jun; 18(1):688. PubMed ID: 29940910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.